207_Combined course Presentations

First page Table of contents Previous page 1705 Next page Last page

Conclusions 1. SCPRT = CRT in resectable cancer 2. cN+ probably inaccurate - most patients pN0 3. Radio-sensitizing 5FU-based CRT with sub therapeutic oxaliplatin ? 4. But minimal benefit for T3N0 on mets 5. Immunotherapy is coming

Made with